Olivier Graber
About Olivier Graber
Olivier Graber is the Head of Process & Technology at Bristol Myers Squibb in Neuchâtel, Switzerland, with extensive experience in the pharmaceutical industry, including roles at Celgene and Baxter Healthcare.
Current Position at Bristol Myers Squibb
Olivier Graber holds the position of Head of Process & Technology at Bristol Myers Squibb. Based in Neuchâtel, Switzerland, he has been with the company since May 2020. In this role, he oversees the development and implementation of technological processes within the organization, leveraging his extensive background in both technical and manufacturing domains within the pharmaceutical industry.
Previous Roles at Celgene
Before joining Bristol Myers Squibb, Olivier Graber had a substantial tenure at Celgene, where he held various roles from 2006 to 2020. His positions included Validation & Qualification Engineer, Validation & Qualification Manager, Associate Director of Validation Services, Associate Director of Manufacturing Technical Services, Sr. Principal Engineer in Drug Process Development, and finally, Technical Leader. In these roles, he was responsible for managing validation and qualification processes, drug process development, and technology transfer.
Career at Baxter Healthcare
Olivier Graber's career began at Baxter Healthcare, where he worked from 2000 to 2006. He started as a Quality Control (QC) Analyst before progressing to QC Coordinator and eventually becoming a Quality Supervisor. His responsibilities included overseeing quality control procedures and ensuring compliance with regulatory standards.
Educational Background
Olivier Graber studied at Ecole Cantonale Neuchâteloise de Technicien de Laboratoire, where he achieved a Diplôme, graduating in 1995. His education laid the foundation for his extensive expertise in quality control and process validation within the pharmaceutical industry.
International Experience in the Pharmaceutical Industry
Olivier Graber has gained significant international experience through his work in both the United States and Switzerland. His roles at Celgene and Baxter Healthcare provided him with a deep understanding of global pharmaceutical standards and practices. This diverse experience has equipped him to handle complex challenges in technology transfer and commercial manufacturing on an international scale.